Fmr LLC Veru Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Veru Inc. stock. As of the latest transaction made, Fmr LLC holds 400 shares of VERU stock, worth $292. This represents 0.0% of its overall portfolio holdings.

Number of Shares

400

Holding current value

$292

% of portfolio

0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.76 - $1.79 $304 - $716	400 New	400 $0
Q4 2023 Feb 13, 2024	SELL	$0.67 - $1.17 $489 - $854	-730 Reduced 94.81%	40 $0
Q3 2023 Nov 13, 2023	SELL	$0.72 - $1.33 $2,093 - $3,867	-2,908 Reduced 79.06%	770 $0
Q2 2023 Aug 11, 2023	SELL	$0.98 - $1.49 $141 - $214	-144 Reduced 3.77%	3,678 $4,000
Q1 2023 May 11, 2023	BUY	$1.16 - $6.41 $3,404 - $18,813	2,935 Added 330.89%	3,822 $4,000
Q4 2022 Feb 13, 2023	SELL	$4.78 - $15.01 $1,974 - $6,199	-413 Reduced 31.77%	887 $4,000
Q3 2022 Nov 10, 2022	SELL	$10.22 - $23.7 $163 - $379	-16 Reduced 1.22%	1,300 $15,000
Q1 2022 May 13, 2022	BUY	$4.55 - $6.41 $5,896 - $8,307	1,296 Added 6480.0%	1,316 $6,000
Q4 2021 Feb 14, 2022	SELL	$5.89 - $9.73 $241 - $398	-41 Reduced 67.21%	20 $0
Q3 2021 Nov 15, 2021	BUY	$6.78 - $9.89 $406 - $593	60 Added 6000.0%	61 $0
Q2 2021 Aug 13, 2021	BUY	$7.24 - $11.2 $7 - $11	1 New	1 $0

Others Institutions Holding VERU

# of Institutions

116

Shares Held

58M

Call Options Held

539K

Put Options Held

367K

Adage Capital Partners Gp, L.L.C. Boston, MA

7.86M
Shares

$5.74 Million
0.01% of portfolio
Black Rock Inc. New York, NY

7.65M
Shares

$5.59 Million
0.0% of portfolio
Perceptive Advisors LLC New York, NY

7.06M
Shares

$5.16 Million
0.17% of portfolio
Vanguard Group Inc Valley Forge, PA

6.11M
Shares

$4.46 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

5.46M
Shares

$3.99 Million
0.0% of portfolio

View Full List

About VERU INC.

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $58.5M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

More about VERU

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account